Publication
Ten-year analgesic utilization patterns and economic implications in Portugal
| dc.contributor.author | Duarte, Nuno | |
| dc.contributor.author | Martins, João Paulo | |
| dc.contributor.author | García-Pedraza, Jose-Ángel | |
| dc.contributor.author | Santos, Marlene | |
| dc.date.accessioned | 2024-11-14T12:44:54Z | |
| dc.date.embargo | 2025-11-14 | |
| dc.date.issued | 2024-11-13 | |
| dc.description.abstract | This study evaluated the 10-year consumption and economic patterns of classical analgesics, adjuvants and opioids in Portugal (2012-2022), and conducted a comparative analysis between Portugal, Spain and Denmark to explore the consumption patterns among these countries for 2022. Data on sales and national health service (NHS) costs were obtained from the Portuguese National Authority of Medicines and Health Products. Sales data were converted to defined daily dose (DDD) per 1000 inhabitants per day according to the Anatomical Therapeutic Chemical (ATC) classification/DDD methodology, while comparisons between Spain and Denmark were evaluated with the chi-square test, when appropriate. The findings reveal that classical analgesics use in Portugal remained stable during the period 2012-2022, with ibuprofen being the most consumed. Adjuvants, specifically gabapentinoids, experienced an 84% increase in use, primarily attributed to pregabalin. Weak opioids, led by tramadol, witnessed a 117% rise in use, while strong opioid use, led by tapentadol, increased by 618%. Portugal presented the lowest overall opioid consumption when compared to Denmark and Spain in 2022. Economic trends indicated a heightened NHS expenditure on analgesics, primarily driven by increased opioid use. Notwithstanding, there was no significant burden on relative expenditure over the 10-year period. Portugal presented a major increase in both weak and strong opioid prescriptions, aligning with the trends for Spain and Denmark. The development and approval of generic medicines and vigilant market monitoring are imperative strategies for managing the escalated costs resulting from heightened consumption, particularly concerning opioids. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Duarte, N., Martins, J. P., García-Pedraza, J.-Á., & Santos, M. (2024). Ten-year analgesic utilization patterns and economic implications in Portugal. British Journal of Clinical Pharmacology, n/a(n/a). https://doi.org/10.1111/bcp.16333 | pt_PT |
| dc.identifier.doi | 10.1111/bcp.16333 | pt_PT |
| dc.identifier.eissn | 1365-2125 | |
| dc.identifier.issn | 0306-5251 | |
| dc.identifier.uri | http://hdl.handle.net/10400.22/26394 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Wiley | pt_PT |
| dc.relation | This work received support and help from FCT/MCTES (LA/P/0008/2020 DOI 10.54499/LA/P/0008/2020, UIDP/50006/2020 DOI 10.54499/UIDP/50006/2020 and UIDB/50006/2020 DOI 10.54499/UIDB/50006/2020). | pt_PT |
| dc.relation.publisherversion | https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16333 | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Analgesic usage patterns | pt_PT |
| dc.subject | Chronic pain management | pt_PT |
| dc.subject | European drug consumption | pt_PT |
| dc.subject | Health care expenditure | pt_PT |
| dc.subject | Opioids | pt_PT |
| dc.title | Ten-year analgesic utilization patterns and economic implications in Portugal | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | British Journal of Clinical Pharmacology | pt_PT |
| person.familyName | Duarte | |
| person.familyName | Oliveira Martins | |
| person.familyName | Santos | |
| person.givenName | Nuno | |
| person.givenName | João Paulo | |
| person.givenName | Marlene | |
| person.identifier | 955929 | |
| person.identifier | 1508370 | |
| person.identifier.ciencia-id | 311A-335C-3FCE | |
| person.identifier.ciencia-id | 6913-C065-48FF | |
| person.identifier.ciencia-id | 8311-B967-31C4 | |
| person.identifier.orcid | 0000-0002-9690-0374 | |
| person.identifier.orcid | 0000-0002-0474-1397 | |
| person.identifier.orcid | 0000-0001-5020-5942 | |
| person.identifier.scopus-author-id | 55838096100 | |
| person.identifier.scopus-author-id | 57110502000 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 7277d917-5b9c-4143-8d6f-8dc02bc71155 | |
| relation.isAuthorOfPublication | 9d1f7388-bb3e-4f1d-bf41-08a589b1d6a8 | |
| relation.isAuthorOfPublication | 8ce9ee39-a4c6-46ae-99e2-49397b550f1b | |
| relation.isAuthorOfPublication.latestForDiscovery | 8ce9ee39-a4c6-46ae-99e2-49397b550f1b |